CN111239219B - Novel composite material for detecting beta-amyloid protein and preparation method and application thereof - Google Patents
Novel composite material for detecting beta-amyloid protein and preparation method and application thereof Download PDFInfo
- Publication number
- CN111239219B CN111239219B CN202010050552.9A CN202010050552A CN111239219B CN 111239219 B CN111239219 B CN 111239219B CN 202010050552 A CN202010050552 A CN 202010050552A CN 111239219 B CN111239219 B CN 111239219B
- Authority
- CN
- China
- Prior art keywords
- amyloid
- heme
- beta
- electrode
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010090849 Amyloid beta-Peptides Proteins 0.000 title claims abstract description 31
- 102000013455 Amyloid beta-Peptides Human genes 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 239000002131 composite material Substances 0.000 title abstract description 9
- 150000003278 haem Chemical class 0.000 claims abstract description 32
- 239000000725 suspension Substances 0.000 claims abstract description 25
- BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 claims abstract description 24
- 229940025294 hemin Drugs 0.000 claims abstract description 24
- 238000001514 detection method Methods 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000008367 deionised water Substances 0.000 claims abstract description 12
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 12
- 238000002156 mixing Methods 0.000 claims abstract description 6
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims abstract description 5
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims abstract description 5
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims abstract description 4
- 235000011114 ammonium hydroxide Nutrition 0.000 claims abstract description 4
- 238000009775 high-speed stirring Methods 0.000 claims abstract description 4
- 238000005406 washing Methods 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 29
- JMANVNJQNLATNU-UHFFFAOYSA-N oxalonitrile Chemical compound N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 7
- 239000010931 gold Substances 0.000 claims description 7
- 229910052737 gold Inorganic materials 0.000 claims description 7
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000005498 polishing Methods 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 230000035484 reaction time Effects 0.000 claims description 4
- 238000009210 therapy by ultrasound Methods 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 7
- 238000003756 stirring Methods 0.000 abstract description 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 230000006399 behavior Effects 0.000 abstract description 2
- 229920001184 polypeptide Polymers 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- 102000009091 Amyloidogenic Proteins Human genes 0.000 description 7
- 108010048112 Amyloidogenic Proteins Proteins 0.000 description 7
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 5
- 208000024827 Alzheimer disease Diseases 0.000 description 4
- 208000037259 Amyloid Plaque Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 239000000872 buffer Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000002135 nanosheet Substances 0.000 description 3
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 238000002848 electrochemical method Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- -1 iron ions Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229960000907 methylthioninium chloride Drugs 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- 208000028698 Cognitive impairment Diseases 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 102000008015 Hemeproteins Human genes 0.000 description 1
- 108010089792 Hemeproteins Proteins 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 241001480789 Neptis ida Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 208000021386 Sjogren Syndrome Diseases 0.000 description 1
- PZBFGYYEXUXCOF-UHFFFAOYSA-N TCEP Chemical compound OC(=O)CCP(CCC(O)=O)CCC(O)=O PZBFGYYEXUXCOF-UHFFFAOYSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 108010075875 amyloid beta-protein (16-20) Proteins 0.000 description 1
- FEWOUVRMGWFWIH-ILZZQXMPSA-N amyloid-beta polypeptide 40 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 FEWOUVRMGWFWIH-ILZZQXMPSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000027697 autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency Diseases 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 208000004209 confusion Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 206010013395 disorientation Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001378 electrochemiluminescence detection Methods 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 description 1
- 238000000504 luminescence detection Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 231100000189 neurotoxic Toxicity 0.000 description 1
- 230000002887 neurotoxic effect Effects 0.000 description 1
- 150000004767 nitrides Chemical class 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000001699 photocatalysis Effects 0.000 description 1
- 238000007146 photocatalysis Methods 0.000 description 1
- 238000001420 photoelectron spectroscopy Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 239000004065 semiconductor Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 102000013498 tau Proteins Human genes 0.000 description 1
- 108010026424 tau Proteins Proteins 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3275—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention discloses a preparation method of a novel composite material for detecting beta-amyloid protein, which is prepared by mixing g-C 3 N 4 Mixing the suspension with Hemin solution, adding ammonia water and hydrazine hydrate under high speed stirring, rapidly stirring, maintaining in 60 deg.C water bath for 4 hr, placing in 4 deg.C refrigerator overnight, centrifuging, washing, and dispersing in secondary deionized water to obtain g-C 3 N 4 -a Heme suspension. The novel composite material for detecting amyloid peptide can be used for constructing a biosensor for detecting beta-amyloid. The sensor is beneficial to the combination of heme and amyloid polypeptide, realizes the detection of amyloid behaviors, has better specificity on amyloid, and can quickly and sensitively realize the early detection of amyloid.
Description
Technical Field
The invention belongs to the field of detection of amyloid, and particularly relates to a novel composite material for detecting beta-amyloid, so that early detection of the amyloid is realized.
Background
Alzheimer's disease is an aging-related neurodegenerative disease, mainly found in the elderly, and is clinically characterized by memory impairment, aphasia, disorientation, cognitive impairment, etc., and gradually worsens with the passage of time. (Jack, C.R.; knoopman, D.S.; jagust, W.J.; shaw, L.M.; aisen, P.S.; weiner, M.W.; petersen, R.C.; trojanowski, J.Q.Lancet neurol.2010,9 (1), 119-128.). The pathogenesis of alzheimer's disease is mainly the amyloid β (a β) hypothesis and the Tau protein hypothesis. The former suggests that amyloid is capable of forming amyloid plaques in the brain of patients, impairing communication between nerve cells. A beta is the main component of neuritic plaques, of which A beta is the main component 1-40 And Abeta 1-42 Two kinds ofThey spontaneously form aggregates of different morphologies, such as oligomers, fibrils and plaques (Spies, p.e.; slips, d.; sjogren, j.m.c.; kremer, b.p.h.; verhey, f.r.j.; rikkert, m.; verbeek, m.m.curr. Alzheimer. Res.2010,7,470-476.Wogulis, m.; wright, s.; cunningham, d.; chilcotle, t.; powell, k.; rydel, r.e.j.neurosci.2005,25, 1071-1080.). In amyloid plaques, A β 1-40 In an amount much higher than Abeta 1-42 Exhibit faster rates of Aggregation, produce more free radical damage, and are considered to be more neurotoxic substances (pelalin, r.; caflisch, a. Inhibiting the Aggregation Kinetics of Amyloid peptides, j. Mol. Biol.2006,360 (4), 882-892.). Studies have shown that in amyloid plaques, the content of some redox-active ions (e.g. copper ions, iron ions) is relatively high, which may be associated with the onset of alzheimer's disease. Wherein the iron ion is mainly present as a counter ion in heme. Heme can be combined with a β to form a complex, and this combination can reduce the biological regulation ability of Heme, resulting in Heme deficiency necessary for normal physiological function (Active Site Environment of blood-Bound Amyloid Peptide Associated with Alzheimer's Disease superb Debase yoti Pramanik, somdata Ghosh Dey, J.Am.chem.Soc.2011,133, 81-87.). The analytical methods commonly used at present for Α β are mainly immunoassays, mass spectrometry and western blotting (j. -h.kang, m.koreka, j.b.toledo, j.q.trojanowski and l.m.shaw, clin.chem.,2013,59,903-916.g.grasso, massspectrum.rev., 2011,30,347-365.n.ida, t.hartmann, j.patel.j.R.Zerfass,H.Sandbrink, C.L.Masters and K.Beyreuther, J.biol.Chem.,1996,271,22908-22914.J.Pannee, E.Portellius, M.Oppermann, A.Atkins, M.Hornshaw, I.Zegers, P.Hojrup, L.Minthon, O.Hansson, H.Zetterg, K.Blennow and J.Gobom, J.Alzheimer's Dis.,2013,33, 1021-1032). Although these methods are well established and are described inAnd the method is used as a reference technology, but miniaturization detection is difficult to realize, so that development of a simple, convenient and miniaturized detection technology has a better application prospect.
Electrochemiluminescence (ECL) is an emerging detection technology, in the sense that ECL is an ideal combination of electrochemical and spectroscopic methods. Therefore, the ECL not only has the sensitivity and wider dynamic range of the traditional chemiluminescence, but also has the advantages of simple, stable and convenient electrochemical method and the like. Terpyridyl ruthenium, luminol, metal nanoclusters, inorganic nitrides and semiconductor quantum dots (Yuan, j., li, t., yin, x.b., guo, l., jiang, x., jin, w., yang, x, wang, e, 2006, anal, chem.78,2934-2938.Li, x, lu, p, wu, b, wang, y, wang, h, du, b, pang, x, wei, q, 2018, biosens, bioelectrron.112, 40-47, zhou, y, chen, m., zhuo, y, chai, y, xu, w, yuan, r, 2017, anal, chem.89,6787-6793, sha, h, zhang, y, wang, y, ke, h, xiong, x, jia, n, 2019, biosens, bioelectron.124-125,59-65, liu, y, lei, j, huang, y, ju, h, 2014, anal.chem.86, 8735-8741) are all commonly used superior luminescent materials. In recent years, carbon nitride nanosheets (g-C) 3 N 4 ) The blue fluorescent label has good biocompatibility and inherent blue fluorescent emission characteristic under ultraviolet irradiation, and can be used as a signal label (Zhang, X.D.; xie, x.; wang, h.; zhang, j.j.; pan, b.c.; xie, y.j.am.chem.soc.2013,135, 18-21.). g-C 3 N 4 The inherent blue fluorescence emission of Cu is also used 2+ Fluorescence Detection of (Tian, J.; liu, Q.; asiri, A.M.; al-Youbi, A.O.; sun, X.Ultrathin graphic Carbon Nitride Nanosheet: AHighly effective fluorescence sensor for Rapid, ultrasensive Detection of Cu 2+ Anal. Chem.2013,85, 5595-5599.). To widen g-C 3 N 4 The application prospect of (a) is that 3 N 4 Compounding with Hemin (Hemin) to successfully prepare the g-C 3 N 4 -Heme composite material having peroxidase activity and capable of catalyzing g-C by utilizing A beta-Heme complex 3 N 4 Electrogenerated chemiluminescence is characterized by the fact that g-C 3 N 4 -the Heme composite for the detection of amyloid peptides.
Disclosure of Invention
Therefore, the present invention is directed to overcoming the drawbacks of the prior art, and the present invention is directed to providing a novel composite material for detecting amyloid peptide, a biosensor for detecting β -amyloid material, and a method for constructing the same.
The term "a β" refers to: beta-amyloid protein (1-40). The term "Hemin" refers to: hemin. The term "Heme" refers to: heme. The term "g-C 3 N 4 "means that: carbon nitride nanosheets. The term "g-C 3 N 4 -Heme "means: a carbon nitride nanosheet-heme complex.
In order to achieve the purpose, the invention adopts the following technical scheme:
a biosensor for detecting beta-amyloid comprises a gold electrode, a DNA fixed chain with sulfydryl at the tail end, beta-amyloid and a carbon nitride nanosheet-heme complex, wherein the DNA fixed chain with sulfydryl at the tail end is loaded on the surface of the gold electrode, the surface of the DNA fixed chain with sulfydryl at the tail end captures the beta-amyloid, and the surface of the beta-amyloid captures the carbon nitride nanosheet-heme complex.
A construction method of a biosensor for detecting beta-amyloid protein specifically comprises the following steps:
(1) Aluminum powder is used for polishing a gold electrode on polishing cloth, the polished electrode is sequentially subjected to ultrasonic treatment in secondary deionized water, ethanol and secondary deionized water for three minutes, then the electrode is dried by nitrogen, and the electrode is placed at 4 ℃ for later use;
(2) Dripping the DNA fixed chain with the sulfydryl at the tail end onto the electrode pretreated in the step (1), and putting the electrode into an oven at 37 ℃ for overnight reaction;
(3) Mixing appropriate amount of carbon nitride nanosheet-heme complex (g-C) 3 N 4 -Heme) suspension was added to different concentrations of beta-amyloid (a β) solution and the electrode treated in step (2) was then placed in this solution.
Further, the g-C 3 N 4 Suspension of Heme, a novel composite for detecting amyloid peptidesThe preparation method specifically comprises the following steps:
(101) Taking a proper amount of g-C 3 N 4 Adding the suspension and the Hemin solution into a round-bottom flask, stirring, mixing the suspension and the Hemin solution for 15 minutes, increasing the rotation speed, adding 400 mu L of ammonia water and 60 mu L of hydrazine hydrate under the condition of high-speed stirring, quickly stirring for 5 minutes, then placing in a water bath kettle at 60 ℃ for keeping for 4 hours, and then placing in a refrigerator at 4 ℃ overnight.
(102) Centrifugally washing the suspension obtained in the step (101) at the rotating speed of 10000 r/min to remove unreacted Hemin, and then dispersing the Hemin in secondary deionized water again to obtain g-C 3 N 4 -a Heme suspension.
Preferably, in said step (101), g-C 3 N 4 The mass ratio to Hemin is (1: 1.
preferably, the solution of step (3) contains amyloid beta and g-C 3 N 4 -the reaction time of Heme is from 2 to 24 hours; most preferably, the reaction time is 12 hours.
Preferably, the pH of the amyloid beta solution in step (3) is: 5.9-8.4; most preferably, the pH is 7.4.
Preferably, g to C in step (3) 3 N 4 -the amount of the Heme suspension added is: 10-60 mu L; most preferably, the material is used in an amount of 50 μ L.
Preferably, said g-C 3 N 4 Has electrochemiluminescence signals under the wavelengths of 425nm, 440nm, 460nm, 490nm, 535nm, 555nm and 575nm, and the optimal electrochemiluminescence signal wavelength is 460nm.
Preferably, the concentration of potassium persulfate in the detection solution of the biosensor is: 0mol/L, 0.5X 10 -1 mol/L、10 -1 mol/L、10 -2 mol/L、10 -3 mol/L; most preferably, the potassium persulfate concentration is10 -1 mol/L。
g-C prepared by the invention 3 N 4 the-Heme can also be applied to the fields of photocatalysis, electrocatalysis and the like.
The invention has the beneficial effects that:
(1) Book (I)The biosensor prepared by the invention can be used for detecting amyloid protein at 1.0X 10 -14 mol/L~1.0×10 -7 Good linearity in the mol/L range.
(2)g-C 3 N 4 the-Heme is applied to an amyloid protein system, is beneficial to the combination of Heme and amyloid protein polypeptide, realizes the detection of amyloid protein behaviors, has better specificity on amyloid protein, and can quickly and sensitively realize the early detection of the amyloid protein.
(3) The biosensor prepared by the invention has the advantages of simple construction method, low cost, good biocompatibility and the like, and enriches new methods for detecting amyloid protein.
Drawings
FIG. 1 is an electrochemical luminescence test chart for verifying the feasibility of the biosensor constructed according to the present invention (a indicates that beta-amyloid is not added, b indicates that beta-amyloid is added, and c indicates that beta-amyloid and methylene blue are added);
FIG. 2 shows Hemin, g-C in the present invention 3 N 4 And g-C 3 N 4 Infrared absorption spectrum of-Heme (a is Hemin, b is g-C) 3 N 4 -Heme, C is g-C 3 N 4 );
FIG. 3 shows Hemin, g-C in the present invention 3 N 4 And g-C 3 N 4 Ultraviolet absorption spectrum of-Heme (a is g-C) 3 N 4 B is g-C 3 N 4 -Heme, c is Hemin);
FIG. 4 shows g-C prepared in the present invention 3 N 4 -XPS spectrogram of Heme;
FIG. 5 is an electrochemical luminescence detection chart (A) and a corresponding standard curve (B) of a biosensor constructed according to the present invention for different concentrations of amyloid beta.
Detailed Description
The technical scheme of the invention is further explained by the specific implementation mode in combination with the attached drawings.
This section generally describes the materials used in the testing of the present invention, as well as the testing methods. Although many materials and methods of operation are known for the purpose of carrying out the invention, the invention is nevertheless described herein in detail as is practicable.
The beta-amyloid used in the following examples was purchased from Shanghai Biopsis GmbH, unless otherwise specified. The beta-amyloid sequence is: DAEFR HDSGY EVHHQ KLVFF AEDVG SNKGA ILGLM VGGVGV.
Unless otherwise specified, the DNA used in the following examples was purchased from Shanghai Biometrics, inc. and had the DNA sequence GCC TGT GGT GTT GGG GCG GGT GCG.
The solvents of the aqueous solutions used in the following examples were twice deionized water unless otherwise specified.
All reagents used in the following examples were analytical reagents unless otherwise specified.
The reagents and instrumentation used in the following examples are as follows:
reagent:
urea, hemin (Hemin), ammonia, hydrazine hydrate, potassium chloride, sodium chloride, disodium hydrogen phosphate, sodium dihydrogen phosphate, potassium persulfate, and Hexafluoroisopropanol (HFIP) were all purchased from Aladdin reagent, inc.
The instrument comprises the following steps:
infrared absorption Spectroscopy, model FT-IR Nicolet iS10.
An ultraviolet absorption spectrometer was purchased from Hitachi, ltd., model No. UH5300.
X photoelectron spectrometer, available from sehmer fisher science, usa, model Thermo ESCALAB 250Xi.
Electrochemiluminescence analyzer, available from sienna ruimmy, model MPI-E.
Example 1
g-C in the present example 3 N 4 The preparation method of the Heme specifically comprises the following steps:
(1) Adding 10g urea into crucible, placing into oven, heating at 20 deg.C/min, maintaining at 550 deg.C for two hours, and naturally cooling to room temperature to obtain block C 3 N 4 。
(2) Taking 100mg blocksC 3 N 4 Dissolving in 100mL of secondary deionized water, ultrasonically crushing for two hours by using a cell crusher, and ultrasonically treating the well-treated g-C 3 N 4 The suspension was stored at 4 ℃ until use.
(3) 5mL of g-C was taken 3 N 4 Adding the suspension and 5mL of 1mg/mL Hemin solution into a round-bottom flask, stirring, mixing the suspension and the Hemin solution for 15 minutes, increasing the rotation speed, adding 400 mu L of ammonia water and 60 mu L of hydrazine hydrate under the condition of high-speed stirring, quickly stirring for 5 minutes, then placing in a 60 ℃ water bath kettle for keeping for 4 hours, and then placing in a 4 ℃ refrigerator overnight.
(4) Centrifuging the suspension obtained in the step (3) for 10 minutes at the rotating speed of 10000 r/min, centrifuging and washing for 3 times, removing unreacted Hemin, and re-dispersing the washed material in secondary deionized water to obtain g-C 3 N 4 -the Heme suspension, kept in a refrigerator at 4 ℃ for future use.
For raw material Hemin, and g-C prepared 3 N 4 And g-C 3 N 4 And (4) performing infrared spectrum characterization on the-Heme, and characterizing the successful preparation of the material through the change of the position of each absorption peak of the infrared absorption spectrum, as shown in figure 2. For raw material Hemin, and g-C prepared 3 N 4 And g-C 3 N 4 the-Heme is subjected to ultraviolet absorption spectrum characterization, and in the ultraviolet absorption, g-C 3 N 4 The significant red shift of Heme due to the incorporation of Heme at the position of the absorption peak, as shown in fig. 3. For g-C 3 N 4 Heme performs X Photoelectron Spectroscopy (XPS) in which the success of preparing the material is indicated by the detection of elements C, N, fe.
Example 2
Preparation of a β solution:
(1) Dissolving the A beta powder in Hexafluoroisopropanol (HFIP) to prepare a Hexafluoroisopropanol (HFIP) solution of 1.0mg/mL, and freeze-drying the prepared solution by using a freeze dryer to form an A beta layered film at the bottom of the test tube.
(2) The freeze-dried a β layered film was dissolved in PBS buffer (pH = 7.4) and formulated into 1.0 × 10 - 6 mol/L of A beta solution at-20 ℃ for standby.
Detection of A beta:
(1) Before experimental testing, a gold electrode is polished on polishing cloth by using 0.05 mu M aluminum powder, the polished electrode is respectively subjected to ultrasonic treatment for three minutes in secondary deionized water, ethanol and secondary deionized water in sequence, the electrode subjected to ultrasonic treatment is dried by using nitrogen, and the electrode is placed at 4 ℃ for standby;
(2) The DNA reagent was allowed to stand at room temperature for 2 minutes, centrifuged at 10000 rpm for 10 minutes, and added with PBS buffer (pH = 7.4) to prepare a solution of a certain concentration. The prepared DNA solution and TCEP solution are mixed to cut the disulfide bonds in the DNA solution, and a DNA fixed chain with a thiol group at the end is obtained.
(3) The DNA-immobilized chain with a thiol group at the end was dropped onto the pretreated electrode, and placed in an oven at 37 ℃ for reaction overnight.
(4) Preparation g-C 3 N 4 Ultrasonically dispersing the Heme suspension for 5 minutes to uniformly disperse the Heme suspension, and taking a certain amount of g-C 3 N 4 The Heme suspension was added to a tube, then different amounts of a β solution were added to make a β standard solution, the treated electrodes were rinsed with PBS buffer solution (pH = 7.4), then placed in a tube, and placed in a constant temperature oven at 37 ℃ for 12 hours. And after incubation, putting the electrode into a detection pool filled with potassium persulfate detection liquid to carry out electrochemiluminescence signal detection, and obtaining a standard curve of the concentration of Abeta and the electrochemiluminescence intensity. Wherein the concentration of the potassium persulfate detection solution is10 -1 mol/L。
In addition, a certain amount of preparation g-C 3 N 4 Ultrasonically dispersing the Heme suspension for 5 minutes to uniformly disperse the Heme suspension, and taking a certain amount of g-C 3 N 4 The Heme suspension was added to the tube, followed by the addition of the a β solution and methylene blue, respectively, and the treated electrode was rinsed with PBS buffer (pH = 7.4), then placed in the tube, and placed in a thermostatic oven at 37 ℃ for 12 hours. After incubation, the electrode is put into a detection cell filled with potassium persulfate detection liquid for electrochemiluminescence signal detection, and a blank sample without A beta solution is set in the process, as shown in figure 1.
Claims (5)
1. A biosensor for detecting beta-amyloid is characterized by comprising a gold electrode, a DNA fixed chain with sulfydryl at the tail end, beta-amyloid and a carbon nitride nanosheet-heme complex, wherein the DNA fixed chain with sulfydryl at the tail end is loaded on the surface of the gold electrode, the surface of the DNA fixed chain with sulfydryl at the tail end captures the beta-amyloid, and the surface of the beta-amyloid captures the carbon nitride nanosheet-heme complex.
2. The method for constructing a biosensor for detecting amyloid beta according to claim 1, comprising the steps of:
(1) Aluminum powder is used for polishing a gold electrode on polishing cloth, the polished electrode is sequentially subjected to ultrasonic treatment in secondary deionized water, ethanol and secondary deionized water for three minutes, then the electrode is dried by nitrogen, and the electrode is placed at 4 ℃ for later use;
(2) Dripping the DNA fixed chain with the sulfydryl at the tail end onto the electrode pretreated in the step (1), and putting the electrode into an oven at 37 ℃ for overnight reaction;
(3) Adding a proper amount of uniformly mixed carbon nitride nanosheet-heme compound suspension into beta-amyloid solutions with different concentrations, and then placing the electrode treated in the step (2) into the solutions;
the preparation method of the carbon nitride nanosheet-heme compound comprises the following steps:
(101) Taking a proper amount of g-C 3 N 4 Uniformly mixing the suspension and the Hemin solution, adding ammonia water and hydrazine hydrate under the condition of high-speed stirring, placing in a water bath kettle at 60 ℃ for 4 hours, and then placing in a refrigerator at 4 ℃ overnight;
(102) And (4) centrifugally washing the suspension finally obtained in the step (101) at the rotating speed of 10000 r/min to remove unreacted Hemin, and then re-dispersing in secondary deionized water.
3. The method for constructing a beta-amyloid-detecting biosensor in accordance with claim 2, wherein in step (101), g-C is used 3 N 4 Substance of HeminThe mass ratio is (1; beta-amyloid and g-C in the solution of the step (3) 3 N 4 -the reaction time of Heme is from 2 to 24 hours; the pH of the beta-amyloid solution in the step (3) is as follows: 5.9-8.4; g-C in step (3) 3 N 4 The amount of the Heme suspension added was: 10-60 mu L; the g to C 3 N 4 Heme has an electrochemiluminescent signal at wavelengths of 425nm, 440nm, 460nm, 490nm, 535nm, 555nm, 575 nm.
4. The method of claim 2, wherein in the step (101), g-C is used as the reference in the step (1) 3 N 4 The mass ratio of the mixed solution to Hemin is 1:1; beta-amyloid and g-C in the solution of the step (3) 3 N 4 -a reaction time of Heme of 12 hours; the pH of the beta-amyloid solution in the step (3) is as follows: 7.4 of the total weight of the mixture; g-C in step (3) 3 N 4 The amount of the Heme suspension added was 50. Mu.L; the g to C 3 N 4 Heme has the strongest electrochemiluminescence signal at a wavelength of 460nm.
5. The method of claim 2, wherein the concentration of potassium persulfate in the detection solution of the biosensor is: 0mol/L, 0.5X 10 -1 mol/L、10 -1 mol/L、10 -2 mol/L or 10 -3 mol/L。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010050552.9A CN111239219B (en) | 2020-01-17 | 2020-01-17 | Novel composite material for detecting beta-amyloid protein and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010050552.9A CN111239219B (en) | 2020-01-17 | 2020-01-17 | Novel composite material for detecting beta-amyloid protein and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111239219A CN111239219A (en) | 2020-06-05 |
CN111239219B true CN111239219B (en) | 2023-01-10 |
Family
ID=70867007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010050552.9A Active CN111239219B (en) | 2020-01-17 | 2020-01-17 | Novel composite material for detecting beta-amyloid protein and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111239219B (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7285396B1 (en) * | 2006-03-30 | 2007-10-23 | Children's Hospital & Research Center At Oakland | Aβ-heme peroxidase |
CN103586064A (en) * | 2013-11-26 | 2014-02-19 | 中国科学院福建物质结构研究所 | Metal/graphite-like carbon nitride compound catalyst and preparing method thereof |
CN104014370B (en) * | 2014-05-30 | 2016-04-20 | 南京理工大学 | A kind of Mimetic Peroxidase, preparation and application thereof |
CN104977341B (en) * | 2015-06-18 | 2017-06-06 | 青岛科技大学 | Graphene houghite piece graphite phase carbon nitride composite ankyrin modified electrode and its preparation method and application |
CN107192749B (en) * | 2017-04-14 | 2019-03-22 | 上海师范大学 | Detect electrochemical luminescence immunosensor and its building of beta-amyloid protein |
CN108273554A (en) * | 2018-01-09 | 2018-07-13 | 西安交通大学 | A kind of g-C3N4The preparation and application of@Hemin compound analogue enztmes |
-
2020
- 2020-01-17 CN CN202010050552.9A patent/CN111239219B/en active Active
Non-Patent Citations (3)
Title |
---|
A label-free and signal-on electrochemiluminescence strategy for sensitive amyloid-beta assay;Haixin Qin 等;《Biosensors and Bioelectronics》;20190624;第141卷;第1-7页 * |
An electrogenerated chemiluminescent biosensor based on a g-C3N4-hemin nanocomposite and hollow gold nanoparticles for the detection of lactate;H.M. Chen 等;《RSC Adv.》;20141231;第4卷;第61759-61766页 * |
电致化学发光技术检测 β-淀粉样蛋白;秦海新 等;《第十一届全国化学生物学学术会议论文摘要(第二卷)》;20191130;第62页 * |
Also Published As
Publication number | Publication date |
---|---|
CN111239219A (en) | 2020-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | A fluorescent biosensor of lysozyme-stabilized copper nanoclusters for the selective detection of glucose | |
CN108384539A (en) | A kind of green fluorescence carbon quantum dot, preparation method and applications | |
CN110643359B (en) | Fluorescent sensor for ascorbic acid detection and preparation method thereof | |
CN110982521B (en) | Graphite phase carbon nitride quantum dot composite and synthetic method and biological application thereof | |
CN110133082B (en) | Electrode material for aptamer sensor, electrochemical aptamer sensor and preparation method of electrochemical aptamer sensor | |
CN112059204B (en) | Preparation method of gold nanoclusters | |
Ahmed et al. | A water-soluble copper-immobilized covalent organic framework functioning as an “OFF–ON” fluorescent sensor for amino acids | |
CN110455769B (en) | Quantitative analysis method for surface enhanced Raman spectroscopy of core-shell nanoparticles with shell as internal standard | |
Zhou et al. | A chiral responsive carbon dots–gold nanoparticle complex mediated by hydrogen peroxide independent of surface modification with chiral ligands | |
Tiwari et al. | An ultra sensitive saccharides detection assay using carboxyl functionalized chitosan containing Gd 2 O 3: Eu 3+ nanoparticles probe | |
CN111239219B (en) | Novel composite material for detecting beta-amyloid protein and preparation method and application thereof | |
Han et al. | A ratiometric nanoprobe consisting of up-conversion nanoparticles functionalized with cobalt oxyhydroxide for detecting and imaging ascorbic acid | |
Liu et al. | Ratiometric fluorescence detection of superoxide anion based on AuNPs‐BSA@ Tb/GMP nanoscale coordination polymers | |
CN110618124A (en) | Method for detecting content of tyramine in aquatic product based on azo coupling reaction and surface enhanced resonance Raman scattering | |
CN110018146B (en) | Method for detecting palladium ions based on fluorescent carbon quantum dots | |
Chen et al. | A novel achiral fluorescent nanoprobe for the chiral recognition of cysteine enantiomers | |
Saedi et al. | A FRET-based aptasensor for the detection of α-synuclein oligomers as biomarkers of Parkinson's disease | |
CN113621366B (en) | Red fluorescent carbon dot and preparation method and application thereof | |
Wang et al. | Fabrication of nitrogen-enriched carbon dots with green fluorescence for enzyme-free detection of uric acid | |
CN111024634B (en) | Prussian blue-based nano probe and preparation method and application thereof | |
CN111286325A (en) | Carbon quantum dot emitting yellow fluorescence and preparation method and application thereof | |
Wu et al. | A fluorescence “turn-on” probe for the respective ratiometric detection of hypochlorite and cysteine | |
CN112552901A (en) | Ratio type zinc ion fluorescent probe and preparation and application thereof | |
CN115260521B (en) | Ratio type palladium-methylene blue coordination polymer nano probe, preparation method and application | |
CN114317682B (en) | Colorimetric-photothermal dual-mode test strip for detecting microRNA and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231201 Address after: Room 1203, 12th Floor, Building 3, No. 8 Haiying Road, Fengtai District, Beijing, 100071 Patentee after: Beijing Zhongkeyi Microbiology Technology Co.,Ltd. Address before: 266061 Qingdao University of Science & Technology, 99 Songling Road, Laoshan District, Qingdao, Shandong Patentee before: QINGDAO University OF SCIENCE AND TECHNOLOGY |
|
TR01 | Transfer of patent right |